Two More Reglan Lawsuits
A pair of additional cases in the ongoing litigation effort against the various manufacturers of Reglan and its generic formulations has been filed, this time in a New Orleans federal court. Attorney Allen Berger is representing both clients, who have filed against several different companies in this matter. The first is Leslie Keeper, who has filed suit against Qualitest Pharmaceuticals, and the second is Ellen Austin. Austin is filing complaint against three companies, specifically Actavis, Actavis Elizabeth and Watson Pharmaceuticals.
Both Austin and Keeper have alleged that they developed Tardive Dyskinesia as a result of being prescribed generic formulations of the antacid-control drug Reglan. Reglan is increasingly being demonstrated as a cause of this condition, which causes distressing and exhausting involuntary movements of the body. Furthermore, there is strong evidence that Reglan results in potentially permanent damage to the nervous system, as this condition never goes away in a significant percentage of patients afflicted with it.
The lawsuits also allege that the companies named distributed false and misleading information. Both plaintiffs assert that the defendants did not provide accurate details about the potential side effects of the medication being prescribed, and did not make a good faith effort to sincerely warn about the potential dangers of Tardive Dyskinesia as a result.
No date has yet been set for the trial, but both plaintiffs are requesting a jury trial in the matter. Each plaintiff is seeking recompense in the form of medical expenses as well as coverage for pain and suffering, mental anguish and physical disfigurement. This is in addition to requesting a judgment to repay their loss of earnings to date, their loss of ability to earn in the future, their overall physical impairment as a result of the medication and, of course, the costs of the court proceedings and a certain portion of interest.
----
